Global Bioimplants Market- By Applications, Trends, Key Driving Factors, Opportunities and Forecast, 2023
Bioimplant are devices of human or animal origin used to replace a missing natural body structure, support an injured biological part, or improve an existing biological structure. The major factors that contribute to the market growth include increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced treatment devices, and growth in awareness regarding both the disease and treatment devices available in the market. However, the stringent approval procedure of the bioimplant is expected to impede the market growth. In addition, significant unmet need in the emerging nations provides a lucrative opportunity for the market.
According to a new report published by Allied Market Research, titled, “Bioimplants Market by Type, and Material: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the market was valued at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% during the forecast period.
Click Here To Access The Sample Report @ https://www.alliedmarketresearch.com/request-sample/4652
The orthopedic bioimplant segment generated the maximum revenue, accounting for nearly 40% of the global digital bioimplant market in 2016. On the other hand, dental bioimplant segment is expected to witness the highest CAGR during the forecast period.
By material, the metallic biomaterial segment is expected to dominate the market, accounting for nearly two-thirds share in 2023. On the other hand, the polymeric biomaterials segment is estimated to register the highest CAGR during the forecast period.
Key Findings of the Bioimplants Market:
- The cardiovascular bioimplant segment contributed for nearly one-fourth share of the global bioimplant market in 2016.
- The spinal bioimplant segment is projected to grow at a significant CAGR from 2017 to 2023.
- The natural biomaterial segment is projected to grow at a significant CAGR during the forecast period.
- Germanyand France are the major shareholders, which collectively accounted for more than one-third share of the Europe bioimplant market in 2016.
- Japanis the major shareholder, accounting for more than one-third share of the Asia-Pacific bioimplant market in 2016.
For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/4652
The North America market is projected to dominate the global bioimplant market in terms of revenue during the forecast period. This is majorly due to the increase in technological development and rise in incidence of cardiac, neuro, and spinal disorders. The Asia-Pacific market is expected to grow at the highest CAGR of 8.7% during the forecast period, owing to rise in awareness about the use of bio implants in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.
Key players of the industry
- Abbott Laboratories (St. Jude Medical, Inc.)
- Boston Scientific Corporation
- Dentsply Sirona Inc.
- Johnson & Johnson (Ethicon, Inc.)
- Medtronic Plc
- Smith & Nephew Plc
- Stryker Corporation
- Victrex Plc. (Invibio Ltd.)
- Wright Medical Group N.V.
- Zimmer Biomet Holdings Inc.
Obtain Report Details: https://www.alliedmarketresearch.com/bioimplants-market
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Market Pulse: https://blog.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
This post was originally published on Pharmaceutical Industry